Abvc Biopharma (ABVC) Return on Sales [ROS] (2009 - 2026)
Abvc Biopharma (ABVC) posted Return on Sales [ROS] of -1776.98% for Q2 2026, down 481.11 percentage points from -1295.87% a year earlier.
Powered by 
Analysis
Abvc Biopharma (ABVC) Return on Sales [ROS] (2009 - 2026) Analysis & Trends
For FY2025, Abvc Biopharma's Return on Sales [ROS] came in at -22503.10%, down 21579.76 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of -20742.23 percentage points (FY2020 to FY2025).
- In prior years, Abvc Biopharma's Return on Sales [ROS] was -923.34% in FY2024 (+3515.90 pp), -4439.24% in FY2023 (-2880.70 pp), -1558.54% in FY2022 (+1731.53 pp) and -3290.07% in FY2021 (-1529.20 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Sales [ROS] since Q4 2024.
- On a year-over-year basis, Return on Sales [ROS] increased in 1 of the last four quarters, with an average year-over-year change of +62.45 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q2 2024, with a gain of 35177.40 percentage points; the weakest was Q1 2024, with a drop of 234053.79 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 32.98% |
| 10 | Abvc Biopharma | 24.28 Mn | 21.86 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,776.98% |
| Jun 30, 2025 | -1,295.87% |
| Dec 31, 2024 | -35,837.44% |
| Sep 30, 2024 | -77.66% |
| Jun 30, 2024 | -734.24% |
| Mar 31, 2024 | -235,539.83% |
| Dec 31, 2023 | -23,641.34% |
| Sep 30, 2023 | -13,566.31% |
| Jun 30, 2023 | -35,911.64% |
| Mar 31, 2023 | -1,486.05% |
| Dec 31, 2022 | -531.92% |
| Sep 30, 2022 | -8,790.94% |
| Jun 30, 2022 | -654.24% |
| Mar 31, 2022 | -24,235.08% |
| Dec 31, 2021 | -3,290.07% |
| Sep 30, 2021 | -1,990.48% |
| Jun 30, 2021 | -6,474.08% |
| Mar 31, 2021 | -476.06% |
| Dec 31, 2020 | -7,799.30% |
| Sep 30, 2020 | -1,116.17% |
API Access
Abvc Biopharma Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();